Whitehawk Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
516
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
WHWK
Whitehawk Therapeutics, Inc. is a preclinical-stage oncology company focused on developing advanced antibody-drug conjugate (ADC) therapies. The company applies next-wave platform technologies to established tumor biology to create treatments for difficult-to-treat cancers. Its portfolio features three ADC assets, which are engineered to overcome the limitations of first-generation predecessors through improved tumor targeting and clinical strategies. These assets are in-licensed from WuXi Biologics under an exclusive agreement for global development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 | 2026-05-29 | English | |
| 8-K | 2026-05-21 | English | |
| 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-13 | English | |
| 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-07 | English | |
| 3 Filing | 2025-12-02 | English | |
| 4 Filing | 2025-12-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 47894348 | S-3 | 2026-05-29 | English | ||
| 46754058 | 8-K | 2026-05-21 | English | ||
| 45579684 | 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-13 | English | ||
| 42980779 | 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-07 | English | ||
|
2025
11 filings
| |||||
| 29677370 | 3 Filing | 2025-12-02 | English | ||
| 29675686 | 4 Filing | 2025-12-02 | English | ||
| 29677454 | 10-Q Filing | 2025-11-06 | English | ||
| 29675803 | 8-K Filing | 2025-11-06 | English | ||
| 29677316 | SCHEDULE 13G Filing | 2025-08-25 | English | ||
| 29677462 | 10-Q Filing | 2025-08-07 | English | ||
| 29677395 | 8-K Filing | 2025-08-07 | English | ||
| 29675718 | 4 Filing | 2025-06-17 | English | ||
| 29675501 | 4 Filing | 2025-06-17 | English | ||
| 29677439 | 4 Filing | 2025-06-16 | English | ||
| 29677425 | 4 Filing | 2025-06-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMAGION BIOSYSTEMS LIMITED
Develops nanoparticle-based imaging for non-invasive cancer…
|
IBX | AU | Professional, scientific and te… |
|
IMCB PJSC
Biotechnology company specializing in personal stem cell ba…
|
GEMA | RU | Professional, scientific and te… |
|
Immuneering Corp
Clinical-stage oncology company developing medicines using …
|
IMRX | US | Professional, scientific and te… |
|
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Clinical-stage biotech developing dual-approach immuno-onco…
|
1541 | HK | Professional, scientific and te… |
|
IMMUNIC, INC.
Develops oral small molecule therapies for chronic inflamma…
|
IMUX | US | Professional, scientific and te… |
|
Immunovant, Inc.
Clinical-stage immunology company developing anti-FcRn anti…
|
IMVT | US | Professional, scientific and te… |
|
IMMUPHARMA PLC
Specialty biopharmaceutical company developing peptide-base…
|
IMM | GB | Professional, scientific and te… |
|
IMMUTEP LIMITED
Develops LAG-3 targeting immunotherapies for cancer and aut…
|
IMM | AU | Professional, scientific and te… |
|
IMMUTEP Ltd
Biotechnology company developing LAG-3 immunotherapies for …
|
IMMP | US | Professional, scientific and te… |
|
IMPACT BIOMEDICAL INC.
Develops biopharmaceutical products and technologies to pro…
|
IBO | US | Professional, scientific and te… |
Whitehawk Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34276/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34276 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34276 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34276 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34276}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Whitehawk Therapeutics, Inc. (id: 34276)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.